Literature DB >> 22191580

Changes in the striatal proteome of YAC128Q mice exhibit gene-environment interactions between mutant huntingtin and manganese.

Michal Wegrzynowicz1, Hunter K Holt, David B Friedman, Aaron B Bowman.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by expansion of a CAG repeat within the Huntingtin (HTT) gene, though the clinical presentation of disease and age-of-onset are strongly influenced by ill-defined environmental factors. We recently reported a gene-environment interaction wherein expression of mutant HTT is associated with neuroprotection against manganese (Mn) toxicity. Here, we are testing the hypothesis that this interaction may be manifested by altered protein expression patterns in striatum, a primary target of both neurodegeneration in HD and neurotoxicity of Mn. To this end, we compared striatal proteomes of wild-type and HD (YAC128Q) mice exposed to vehicle or Mn. Principal component analysis of proteomic data revealed that Mn exposure disrupted a segregation of WT versus mutant proteomes by the major principal component observed in vehicle-exposed mice. Identification of altered proteins revealed novel markers of Mn toxicity, particularly proteins involved in glycolysis, excitotoxicity, and cytoskeletal dynamics. In addition, YAC128Q-dependent changes suggest that axonal pathology may be an early feature in HD pathogenesis. Finally, for several proteins, genotype-specific responses to Mn were observed. These differences include increased sensitivity to exposure in YAC128Q mice (UBQLN1) and amelioration of some mutant HTT-induced alterations (SAE1, ENO1). We conclude that the interaction of Mn and mutant HTT may suppress proteomic phenotypes of YAC128Q mice, which could reveal potential targets in novel treatment strategies for HD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22191580      PMCID: PMC3319668          DOI: 10.1021/pr200839d

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  98 in total

1.  Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses.

Authors:  Weidong Zhou; Jennifer J Ryan; Huilin Zhou
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

2.  The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey.

Authors:  E D Bird; A H Anton; B Bullock
Journal:  Neurotoxicology       Date:  1984       Impact factor: 4.294

3.  Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates.

Authors:  Hiroshi Doi; Kenichi Mitsui; Masaru Kurosawa; Yoko Machida; Yoshiyuki Kuroiwa; Nobuyuki Nukina
Journal:  FEBS Lett       Date:  2004-07-30       Impact factor: 4.124

4.  Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322.

Authors:  Zhong-Ying Mo; Ying-Zhu Zhu; Hai-Li Zhu; Jun-Bao Fan; Jie Chen; Yi Liang
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

5.  A bioluminescent assay for enolase (EC 4.2.1.11) activity in human serum and cerebrospinal fluid.

Authors:  R A Wevers; A A Jacobs; O R Hommes
Journal:  Clin Chim Acta       Date:  1983-12-15       Impact factor: 3.786

6.  SUMO modification of Huntingtin and Huntington's disease pathology.

Authors:  Joan S Steffan; Namita Agrawal; Judit Pallos; Erica Rockabrand; Lloyd C Trotman; Natalia Slepko; Katalin Illes; Tamas Lukacsovich; Ya-Zhen Zhu; Elena Cattaneo; Pier Paolo Pandolfi; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Science       Date:  2004-04-02       Impact factor: 47.728

7.  Enzyme relationships in a sorbitol pathway that bypasses glycolysis and pentose phosphates in glucose metabolism.

Authors:  J Jeffery; H Jörnvall
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

Review 8.  Huntingtin-protein interactions and the pathogenesis of Huntington's disease.

Authors:  Shi-Hua Li; Xiao-Jiang Li
Journal:  Trends Genet       Date:  2004-03       Impact factor: 11.639

9.  Cerebellar atrophy in Huntington's disease.

Authors:  R A Rodda
Journal:  J Neurol Sci       Date:  1981-04       Impact factor: 3.181

10.  Alterations in brain dopamine and GABA following inorganic or organic manganese administration.

Authors:  G Gianutsos; M T Murray
Journal:  Neurotoxicology       Date:  1982-11       Impact factor: 4.294

View more
  12 in total

1.  Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains.

Authors:  Tamara Ratovitski; Raghothama Chaerkady; Kai Kammers; Jacqueline C Stewart; Anialak Zavala; Olga Pletnikova; Juan C Troncoso; Dobrila D Rudnicki; Russell L Margolis; Robert N Cole; Christopher A Ross
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

2.  Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model.

Authors:  Terry Jo V Bichell; Michal Wegrzynowicz; K Grace Tipps; Emma M Bradley; Michael A Uhouse; Miles Bryan; Kyle Horning; Nicole Fisher; Karrie Dudek; Timothy Halbesma; Preethi Umashanker; Andrew D Stubbs; Hunter K Holt; Gunnar F Kwakye; Andrew M Tidball; Roger J Colbran; Michael Aschner; M Diana Neely; Alba Di Pardo; Vittorio Maglione; Alexander Osmand; Aaron B Bowman
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-16       Impact factor: 5.187

3.  Effect of pesticides on the aggregation of mutant huntingtin protein.

Authors:  Ruhi S Deshmukh; Rajeev K Chaudhary; Ipsita Roy
Journal:  Mol Neurobiol       Date:  2012-03-14       Impact factor: 5.590

4.  BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity.

Authors:  Kirstie H Stansfield; Terry Jo Bichell; Aaron B Bowman; Tomás R Guilarte
Journal:  J Neurochem       Date:  2014-09-02       Impact factor: 5.372

5.  Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.

Authors:  Michal Wegrzynowicz; Terry Jo Bichell; Barbara D Soares; Meredith K Loth; Jennifer S McGlothan; Susumu Mori; Fatima S Alikhan; Kegang Hua; Jennifer M Coughlin; Hunter K Holt; Christopher S Jetter; Martin G Pomper; Alexander P Osmand; Tomás R Guilarte; Aaron B Bowman
Journal:  J Huntingtons Dis       Date:  2015

6.  Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.

Authors:  Guiran Xiao; Qiangwang Fan; Xiaoxi Wang; Bing Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 7.  Manganese toxicity in the central nervous system: the glutamine/glutamate-γ-aminobutyric acid cycle.

Authors:  M Sidoryk-Wegrzynowicz; M Aschner
Journal:  J Intern Med       Date:  2013-05       Impact factor: 8.989

Review 8.  Manganese-induced neurodegenerative diseases and possible therapeutic approaches.

Authors:  Airton C Martins; Priscila Gubert; Gustavo R Villas Boas; Marina Meirelles Paes; Abel Santamaría; Eunsook Lee; Alexey A Tinkov; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2020-09-02       Impact factor: 4.618

Review 9.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

10.  Anatomo-proteomic characterization of human basal ganglia: focus on striatum and globus pallidus.

Authors:  Joaquín Fernández-Irigoyen; María Victoria Zelaya; Teresa Tuñon; Enrique Santamaría
Journal:  Mol Brain       Date:  2014-11-18       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.